Australia TGA ARTG recordStimulator, electrical, analgesic, peripheral nerve, implantable
Australia TGA ARTG Registered Device · Algostim Research & Development Pty Limited · Bioness Inc · Class IIb · Started January 17, 2019
Good Name: Algostim Research & Development Pty Limited - Stimulator, electrical, analgesic, peripheral nerve, implantable
- Risk Class
- Class IIb
- Product Type
- Medical device system
- ARTG Category
- General
- Start Date
- January 17, 2019
- Effective Date
- January 17, 2019
- Name
- Bioness Inc
- Country
- United States of America
- Address
- 25103 Rye Canyon Loop, Valencia, CA, 91355
The StimRouter is indicated for pain management in adults who have severe intractable chronic pain of peripheral nerve origin as an adjunct to other modes of therapy ( e.g., medications). The StimRouter is not intended to treat pain of craniofacial nerve origin.
Access comprehensive regulatory information for Stimulator, electrical, analgesic, peripheral nerve, implantable in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Algostim Research & Development Pty Limited, manufactured by Bioness Inc in United States of America. The device registration started on January 17, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.